1-15 of 15 results for subject:Snuff
Librarians' tools
- Search time
- 0.199 seconds
- Solr query time
- 0.002 seconds
- Search query
- subject:Snuff
- We searched for
- subject_t:Snuff OR subject_ses:12858
Type
House
Session
Year
Department
Member
More
Primary member
Answering member
Legislative stage
Legislation
Subject
More
Publisher
Clause 47 agreed to on division (16 votes to 1). Clauses 48 and 49 agreed to. Amendments to clause 50 negatived on division (3 votes to 13 and 3 votes to 11). Clauses 50 to 57 agreed to. Amendments to clause 58 negatived on division (3 votes to 11 in each case). Clauses 58 to 67 agreed to. Schedules 8 and 9 agreed to. Amendments to clause 68 negatived on division (2 votes to 13 in each case). Clause 68 agreed to. Amendments to clause 69 negatived on division (2 votes to 13 in each case). Clauses 69 to 74 agreed to. Amendment to clause 75 negatived on division (2 votes to 13). Clause 75 agreed to. Amendment to clause 76 negatived on division (2 votes to 13). Clause 76 agreed to. Amendments to clause 77 negatived on division (3 votes to 13 in each case). Clauses 77 to 88 agreed to. Schedules 10 to 15 agreed to. Clause 89 under consideration when the Committee adjourned.
Clause 47 agreed to on division (16 votes to 1). Clauses 48 and 49 agreed to. Amendments to clause 50 negatived on division (3 votes to 13 and 3 votes to 11). Clauses 50 to 57 agreed to. Amendments to clause 58 negatived on division (3 votes to 11 in...
To ask the Secretary of State for Health and Social Care, if she will make an estimate of the number of hospital admissions for issues related to the taking of snuff in the last (a) 12 months, (b) five years and (c) 20 years.
To ask the Secretary of State for Health and Social Care, if she will make an estimate of the number of hospital admissions for issues related to the taking of snuff in the last (a) 12 months, (b) five years and (c) 20 years.
Smoking is responsible for approximately 80,000 deaths a year in the United Kingdom, and causes around one in four UK cancer deaths. It also costs our country £21.8 billion a year, and puts a huge burden on the National Health Service. The latest estimates from Action on Smoking and Health put the cost of smoking to the NHS at £1.9 billion a year.
All tobacco products are harmful. Tobacco smoke from cigars leads to the same types of diseases as cigarette smoke. Research has shown that using smokeless tobacco raises the risk of both mouth and oesophageal cancer. Data from the Office for Health Improvement and Disparities’ Smoking Profile showed that in 2019/20 there were an estimated 448,031 smoking attributable hospital admissions, but we cannot differentiate by the type of tobacco.
As such, the Department does not hold data on the annual costs to the NHS of cigar smoking and snuff taking, nor data on the number of hospital admissions for issues related to cigar smoking or snuff taking in the last 12 months, five years, or 20 years.
To ask the Secretary of State for Health and Social Care, if she will make an estimate of the annual cost to the NHS of (a) cigar smoking and (b) snuff taking.
To ask the Secretary of State for Health and Social Care, if she will make an estimate of the annual cost to the NHS of (a) cigar smoking and (b) snuff taking.
Smoking is responsible for approximately 80,000 deaths a year in the United Kingdom, and causes around one in four UK cancer deaths. It also costs our country £21.8 billion a year, and puts a huge burden on the National Health Service. The latest estimates from Action on Smoking and Health put the cost of smoking to the NHS at £1.9 billion a year.
All tobacco products are harmful. Tobacco smoke from cigars leads to the same types of diseases as cigarette smoke. Research has shown that using smokeless tobacco raises the risk of both mouth and oesophageal cancer. Data from the Office for Health Improvement and Disparities’ Smoking Profile showed that in 2019/20 there were an estimated 448,031 smoking attributable hospital admissions, but we cannot differentiate by the type of tobacco.
As such, the Department does not hold data on the annual costs to the NHS of cigar smoking and snuff taking, nor data on the number of hospital admissions for issues related to cigar smoking or snuff taking in the last 12 months, five years, or 20 years.
To ask the Secretary of State for Health and Social Care, with reference to her Department's policy paper entitled Stopping the start: our new plan to create a smokefree generation, published on 8 November 2023, whether it is her policy to include snuff tobacco products in these proposals.
To ask the Secretary of State for Health and Social Care, with reference to her Department's policy paper entitled Stopping the start: our new plan to create a smokefree generation, published on 8 November 2023, whether it is her policy to include snuff tobacco products in these proposals.
Smoking is responsible for approximately 80,000 deaths a year in the United Kingdom and causes approximately one in four cancer deaths. It also costs our country £17 billion a year and puts a huge burden on the National Health Service. That is why we will introduce the Tobacco and Vapes Bill in this parliamentary session to create the first smokefree generation and crack down on youth vaping
In October 2023, the Government and devolved administrations launched a public consultation on the smokefree generation and youth vaping. For the smokefree generation policy, where tobacco products would not be sold to those who turned 15 years old or younger this year, the consultation included a question on whether respondents agreed with the proposed approach to mirror the existing age of sale legislation in England and Wales. This included:
- cigarettes;
- cigarette papers;
- hand rolled tobacco;
- cigars;
- cigarillos;
- pipe tobacco;
- waterpipe tobacco products, for example, shisha;
- chewing tobacco;
- heated tobacco;
- nasal tobacco; and
- herbal smoking products.
The consultation response will be published shortly
As outlined in command paper published on 4 October 2023, our position is that all tobacco products are harmful, and the evidence is clear that there is no safe level of tobacco consumption. Tobacco smoke from shisha and cigars lead to the same types of diseases as cigarette smoke. Snus is banned in the UK and we have no plans to introduce additional tobacco products to the UK market.
Vapes are tobacco-free so outside the proposed scope of the smokefree generation policy. In our consultation, we asked questions about policies which have the potential to reduce the appeal, availability, and affordability of vaping to children. It is clear that vaping is totally unsuitable for children. However, we want to ensure that vapes remain available as a smoking cessation tool for adult smokers given the lesser harms posed to smokers from vaping.
Motion to consider. Agreed to on question.
Motion to consider. Agreed to on question.
To ask the hon. Member for Caithness, Sutherland and Easter Ross, representing the House of Commons Commission, how much snuff was administered to hon. Members by the doorkeepers in the last 10 years; and at what cost.
To ask the hon. Member for Caithness, Sutherland and Easter Ross, representing the House of Commons Commission, how much snuff was administered to hon. Members by the doorkeepers in the last 10 years; and at what cost.
A snuff box is located in the Principal Doorkeeper's chair. It is unusual for Members to request snuff, and there are no regular users of this facility. No records of usage or cost are maintained. Recent practice has been for this tradition to be maintained at the Principal Doorkeeper’s personal expense.
Scientific Committee on Emerging and Newly Identified Health Risks - SCENIHR. Health effects of smokeless tobacco products. 157 p.
Scientific Committee on Emerging and Newly Identified Health Risks - SCENIHR. Health effects of smokeless tobacco products. 157 p.
To ask the Secretary of State for Health (1) if he will request (a) his Department's Chief Scientific Adviser and (b) the Government's Chief Scientific Advisers' Committee to conduct an assessment of the published scientific evidence concerning the health risks associated with the use of Swedish snus and other forms...
To ask the Secretary of State for Health (1) if he will request (a) his Department's Chief Scientific Adviser and (b) the Government's Chief Scientific Advisers' Committee to conduct an assessment of the published scientific evidence concerning the health risks associated with the use of Swedish snus and other forms...
Directive 2001/37/EC of the European Parliament and of the Council of 5 June 2001 concerning the manufacture, presentation and sale of tobacco products prohibits the placing on the market of tobacco for oral use, including snus.
In February 2008, the European Commission's independent Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR) published a report titled “Health Effects of Smokeless Tobacco Products” that reviewed the evidence on the safety of smokeless tobacco products. SCENIHR concluded that smokeless tobacco products are addictive and their use is hazardous to health.
The SCENIHR is one of three independent non-food Scientific Committees that provide the European
Commission with scientific advice to support policy development relating to consumer safety, public health and the environment.
The Government is satisfied that SCENIHR's report is comprehensive, and has no plans to undertake any further specific reviews into the safety of snus.
A copy of SCENIHR's report has been placed in the Library.
(2) with reference to paragraph 5.11 of his Department's Tobacco Control Plan for England, Healthy Lives, Healthy People, if he will cite the scientific evidence used to assess the health risks associated with the use of smokeless tobacco.
[133461]
Paul Flynn:
(2) with reference to paragraph 5.11 of his Department's Tobacco Control Plan for England, Healthy Lives, Healthy People, if he will cite the scientific evidence used to assess the health risks associated with the use of smokeless tobacco.
[133461]
Paul Flynn:
Directive 2001/37/EC of the European Parliament and of the Council of 5 June 2001 concerning the manufacture, presentation and sale of tobacco products prohibits the placing on the market of tobacco for oral use, including snus.
In February 2008, the European Commission's independent Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR) published a report titled “Health Effects of Smokeless Tobacco Products” that reviewed the evidence on the safety of smokeless tobacco products. SCENIHR concluded that smokeless tobacco products are addictive and their use is hazardous to health.
The SCENIHR is one of three independent non-food Scientific Committees that provide the European
Commission with scientific advice to support policy development relating to consumer safety, public health and the environment.
The Government is satisfied that SCENIHR's report is comprehensive, and has no plans to undertake any further specific reviews into the safety of snus.
A copy of SCENIHR's report has been placed in the Library.
That this House welcomes the confirmation from Cancer Research UK Action on Smoking and Health and the Royal College of Physicians that some forms of smokeless tobacco are between 500 and 1,000 times less hazardous than smoking tobacco; agrees with the conclusion that, if Britain followed the Swedish pattern of smokeless tobacco use, tobacco-related deaths among men would be cut by 44,000 a year; and urges the Government to end the ban on the sale of snus which will allow inveterate smokers access to a safer alternative that would add several years to their life expectancies.
That this House welcomes the confirmation from Cancer Research UK Action on Smoking and Health and the Royal College of Physicians that some forms of smokeless tobacco are between 500 and 1,000 times less hazardous than smoking tobacco; agrees with the conclusion that, if Britain followed the Swedish pattern of...
That this House welcomes the confirmation from Government that smokeless tobacco is less dangerous than cigarettes and the remarkable reduction of cancer deaths in Sweden as a result of smokeless tobacco use; notes that smokeless tobacco is used as an aid by a third of Swedes who quit smoking; is persuaded by the Royal College of Physicians' view that smokeless tobacco can be up to 1,000 times less hazardous than smoking tobacco in addition to reducing the harmful effects of passive smoking; and believes that the UK ban on the use of Snus moist snuff should be removed so that its health advantages can be shared by inveterate British smokers.
That this House welcomes the confirmation from Government that smokeless tobacco is less dangerous than cigarettes and the remarkable reduction of cancer deaths in Sweden as a result of smokeless tobacco use; notes that smokeless tobacco is used as an aid by a third of Swedes who quit smoking; is...
That this House welcomes the remarkable reduction of cancer deaths in Sweden following the drop in smoking by Swedish males from 36 per cent. of the population in 1980 to 17 per cent. now; notes that smokeless tobacco is used by half of Sweden's male tobacco users but is rare among women resulting in cancer male deaths that are half the European average while female cancer deaths are almost exactly the European average; further notes that smokeless tobacco is used as an aid by a third of Swedes who quit smoking; is convinced by the research that smoking reduces life expectancy for a 35 year old smoker by eight years compared with a reduction of a mere 15 days by smokeless tobacco; is persuaded by the Royal College of Physicians view that smokeless tobacco can be up to 1,000 times less hazardous than smoking tobacco; and believes that the UK ban on the use of Snus moist snuff should be removed so that is health advantages can be shared by British nicotine addicts.
That this House welcomes the remarkable reduction of cancer deaths in Sweden following the drop in smoking by Swedish males from 36 per cent. of the population in 1980 to 17 per cent. now; notes that smokeless tobacco is used by half of Sweden's male tobacco users but is rare...
Westminster Hall adjournment debate on smokeless tobacco (moist snuff or snus)
Westminster Hall adjournment debate on smokeless tobacco (moist snuff or snus)
Tobacco Advertising and Promotion Bill (HL). Lords debate on motion that the House do now resolve itself into a committee, agreed to on question. Lords Committee stage first day. Clauses 1-3 agreed to.
Tobacco Advertising and Promotion Bill (HL). Lords debate on motion that the House do now resolve itself into a committee, agreed to on question. Lords Committee stage first day. Clauses 1-3 agreed to.
List of scientific evidence for banning snuff: bibliography. DH. 1992.
List of scientific evidence for banning snuff: bibliography. DH. 1992.